Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease
NCT01963845
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Non-alcoholic Fatty Liver Disease
Interventions
DRUG:
Sitagliptin
DRUG:
Placebo
Sponsor
University of California, San Diego